©2013 Baishideng Publishing Group Co.
World J Clin Oncol. Nov 10, 2013; 4(4): 85-90
Published online Nov 10, 2013. doi: 10.5306/wjco.v4.i4.85
Published online Nov 10, 2013. doi: 10.5306/wjco.v4.i4.85
Table 1 Risk factors for the development of squamous cell carcinoma of the skin
| Exposure to ultraviolet (UV) radiation (UVA, UVB) |
| Therapy with methoxalen and UVA |
| Fair skin type |
| Ionizing radiation |
| Genodermatosis (albinism, xeroderma pigmentosum, epidermolysis bullosa) |
| Chronic inflammation of skin (lupus erythematosus, epidermolysis bullosa) |
| Chronically injured skin with ulcers (burn scars, leg ulcers, epidermolysis bullosa) |
| Human papilloma virus infection |
| Exposure to chemical carcinogens |
| Immunosuppression |
| Immunosuppressive medications |
| Organ transplantation |
| Osteomyelitis |
| Sinus tracts |
| Precursor lesions (actinic and arsenical keratoses) |
| In situ squamous cell carcinoma (Bowen’s disease and Erythro plasia Queyrat) |
| Tobacco smoking |
| Leukemia and lymphoma |
- Citation: Kivisaari A, Kähäri VM. Squamous cell carcinoma of the skin: Emerging need for novel biomarkers. World J Clin Oncol 2013; 4(4): 85-90
- URL: https://www.wjgnet.com/2218-4333/full/v4/i4/85.htm
- DOI: https://dx.doi.org/10.5306/wjco.v4.i4.85